US 9108921
Therapeutic compounds and compositions
granted A61PA61P35/00A61P35/02
Quick answer
US patent 9108921 (Therapeutic compounds and compositions) held by Agios Pharmaceuticals, Inc. expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00, A61P7/06